JGES consensus meeting report in DDW–japan 2000, kobe: role of covered metallic stent today

2002 ◽  
Vol 14 (4) ◽  
pp. 188-189
Author(s):  
Tetsuya Mine
Keyword(s):  
Consensus Meeting ◽  
Meeting Report ◽  
Metallic Stent ◽  
Covered Metallic Stent

scholarly journals Salvage therapy of bleeding esophageal tumor by fully covered self-expandable metallic stent: A case report

2021 ◽  
Vol 9 ◽  
pp. 2050313X2199719
Author(s):  
Sundus Bilal ◽  
Saad Muhammad Saeed ◽  
Muhammad Zeeshan Siddique ◽  
Muhammad Saqib ◽  
Shafqat Mehmood ◽  
...  
Keyword(s):  
Case Reports ◽  
Esophageal Tumor ◽  
Metallic Stent ◽  
Diverse Group ◽  
Expandable Metallic Stent ◽  
Lost To Follow Up ◽  
Expandable Metallic Stents ◽  
Tamponade Effect

The role of self-expandable metallic stents is gradually evolving for a diverse group of benign and malignant gastrointestinal tract problems, with luminal obstruction being by far the most common. Although its role in refractory variceal bleeding is well established, it has rarely been tried for tumor-related bleeding, with only a few case reports in this regard. We share our experience of successfully controlling esophageal tumor–related bleeding with the use of a fully covered self-expandable metallic stent. A 58-year-old woman with irresectable distal esophageal cancer, presented with hematemesis. Esophago-gastro-duodenoscopy revealed an obstructing esophageal tumor with diffuse oozing of blood. This was unamenable to local injection of adrenaline and hemospray; therefore, a temporary self-expandable metallic stent was parked to create a tamponade effect. This successfully stopped bleeding and the patient remained asymptomatic till discharge. However, she was lost to follow-up, and therefore, the stent was removed after a period of 5 months instead of 2 weeks.

Percutaneous use of ePTFE/FEP-covered metallic stent for palliation of malignant biliary obstruction

2014 ◽  
Vol 23 (6) ◽  
pp. 366-373
Author(s):  
Charles Edouard Zurstrassen ◽  
Aline Cristine Barbosa Santos ◽  
Chiang Jeng Tyng ◽  
João Paulo Matushita ◽  
Felipe Jose Coimbra ◽  
...  
Keyword(s):  
Biliary Obstruction ◽  
Malignant Biliary Obstruction ◽  
Metallic Stent ◽  
Covered Metallic Stent

scholarly journals Comparison of early and delayed EUS-guided drainage of pancreatic fluid collection

2018 ◽  
Vol 06 (12) ◽  
pp. E1398-E1405 ◽  
Author(s):  
Tanyaporn Chantarojanasiri ◽  
Natsuyo Yamamoto ◽  
Yousuke Nakai ◽  
Tomotaka Saito ◽  
Kei Saito ◽  
...  
Keyword(s):  
Acute Pancreatitis ◽  
Gastrointestinal Tract ◽  
Fluid Collection ◽  
Adverse Event Rate ◽  
Plastic Stents ◽  
Endoscopic Drainage ◽  
Metallic Stent ◽  
Pancreatic Fluid Collection ◽  
Pancreatic Fluid ◽  
Covered Metallic Stent

Abstract Background and study aims While endoscopic ultrasound (EUS)-guided drainage of pancreatic fluid collection (PFC) is recommended to be performed ≥ 4 weeks after onset of acute pancreatitis (AP), early (< 4 weeks) interventions are needed in some symptomatic cases. Despite feasibility of early percutaneous drainage, there have been few studies about early EUS-guided drainage of PFC. Patients and methods Consecutive patients who received EUS-guided drainage (EUS-PCD) of infected or symptomatic PFC at the University of Tokyo were retrospectively studied. Contraindications for EUS-PCD are lack of encapsulation or adhesion to the gastrointestinal tract. Safety and effectiveness of early vs delayed (≥ 4 weeks) EUS-PCD were compared. Results A total of 35 patients underwent EUS-PCD (12 early and 23 delayed) using 19 large-bore fully-covered metallic stent and 16 plastic stents. The median diameter of PFC was 110 mm (40 – 180) and 122 mm (17 – 250) in the early and delayed drainage groups, respectively. Median time from onset of AP to drainage was 23 and 85 days for early and delayed drainage, respectively. The technical success rate of EUS-guided drainage was 100 %. Endoscopic necrosectomy was performed in six early and 16 cases of delayed drainage. The adverse event rate was 25 % (3 bleeding) and 13 % (2 perforations and 1 CO2 retention) in the early and delayed drainage groups, respectively. Two patients died (1 early and 1 delayed) due to multiorgan failure. Conclusion Endoscopic drainage and subsequent necrosectomy of symptomatic PFC within 4 weeks after onset of acute pancreatitis was feasible, given that the collection was encapsulated and attached to the gastrointestinal tract.

Peroral placement of a self-expandable covered metallic stent using an overtube for malignant gastroduodenal obstructions

Surgery Today ◽  
2011 ◽  
Vol 41 (5) ◽  
pp. 637-642 ◽  
Author(s):  
Tetsuo Ikeda ◽  
Naoyuki Ueda ◽  
Yusuke Yonemura ◽  
Kohjiro Mashino ◽  
Akira Kabashima ◽  
...  
Keyword(s):  
Metallic Stent ◽  
Covered Metallic Stent

scholarly journals Consensus Meeting Report “Technology Enhanced Assessment” in Covid-19 Time, MENA Regional Experiences and Reflections

2021 ◽  
Vol Volume 12 ◽  
pp. 1449-1456
Author(s):  
Nagwa N Hegazy ◽  
Noha M Elrafie ◽  
Nermine Saleh ◽  
Ilham Youssry ◽  
Samar A Ahmed ◽  
...  
Keyword(s):  
Consensus Meeting ◽  
Meeting Report

scholarly journals NECROTIZING PANCREATITIS: DESCRIPTION OF VIDEOSCOPIC ASSISTED RETROPERITONEAL DEBRIDEMENT (VARD) TECHNIQUE WITH COVERED METALLIC STENT

2018 ◽  
Vol 31 (2) ◽  
Author(s):  
Eduardo J. HOUGHTON ◽  
Alain A. García VÁZQUEZ ◽  
Manuel E. ZELEDÓN ◽  
Andrea ANDREACCHIO ◽  
Gabriel RUIZ ◽  
...  
Keyword(s):  
Guide Wire ◽  
Necrotizing Pancreatitis ◽  
Gastrointestinal Disorder ◽  
The United States ◽  
Metallic Stent ◽  
Partial Recovery ◽  
Invasive Treatment ◽  
Infected Necrosis ◽  
Treatment Techniques ◽  
Covered Metallic Stent

ABSTRACT Background : Acute pancreatitis is the third most common gastrointestinal disorder requiring hospitalization in the United States, with annual costs exceeding $2 billions. Severe necrotizing pancreatitis is a life-threatening complication developed in approximately 20% of patients. Its mortality rate range from 15% in patients with sterile necrosis to up 30% in case of infected one associated with multi-organ failure. Less invasive treatment techniques are increasingly being used. These techniques can be performed in a so-called step-up approach. Aim: To present the technique for videoscopic assisted retroperitoneal debridement (Vard technique) with covered metallic stent in necrotizing pancreatitis. Method: A guide wire was inserted through the previous catheter that was removed in the next step. Afterwards, the tract was dilated over the guide wire. Then, a partially covered metallic stent was deployed. A 30 degrees laparoscopic camera was inserted and the necrosis removed with forceps through the expanded stent under direct vision. Finally, the stent was removed and a new catheter left in place. Result : This technique was used in a 31-year-old man with acute pain in the upper abdomen and diagnosed as acute biliary pancreatitis with infected necrosis. He was treated with percutaneous drains at weeks 3, 6 and 8. Due to partial recovery, a left lateral VARD was performed (incomplete by fixed and adherent tissue) at 8th week. As the patient´s inflammatory response was reactivated, a second VARD attempt was performed in three weeks later. Afterwards, patient showed complete clinical and imaging resolution. Conclusions : Videoassisted retroperitoneal necrosectomy using partially covered metallic stent is a feasible technique for necrotizing pancreatitis.

scholarly journals Self-expandable covered metallic stent as a conduit for pancreatic stone extraction

Endoscopy ◽  
2018 ◽  
Vol 50 (09) ◽  
pp. E262-E263
Author(s):  
Heather Branstetter ◽  
Umangi Patel ◽  
Prashant Kedia ◽  
Paul Tarnasky
Keyword(s):  
Metallic Stent ◽  
Stone Extraction ◽  
Pancreatic Stone ◽  
Covered Metallic Stent

Gastric cancer

2016 ◽  
pp. 388-407
Author(s):  
Hideaki Bando ◽  
Takahiro Kinoshita ◽  
Yasutoshi Kuboki ◽  
Atsushi Ohtsu ◽  
Kohei Shitara
Keyword(s):  
Gastric Cancer ◽  
Metallic Stent ◽  
Curative Surgery ◽  
Curative Intent ◽  
Expandable Metallic Stent ◽  
Pain Medications ◽  
Gastric Stenosis ◽  
Environmental Causes ◽  
Endoscopic Placement

This chapter covers gastric cancers, beginning with epidemiology and molecular biology, including the association between Helicobacter pylori infection and gastric cancer, and other genetic and environmental causes. The role of surgical therapy in the treatment of gastric cancer including staging and resection with curative intent is presented. The medical management of gastric cancer is discussed, including adjuvant therapy after curative surgery and systemic treatment for palliation of metastatic disease, taking into account the differing biology and treatments in the East and West. The use of the first biologics in gastric cancer, trastuzumab and ramucirumab, and their mechanisms of action are described. Various modes of palliation of symptoms in patients with advanced gastric cancer include: gastrojejunostomy, endoscopic placement of a self-expandable metallic stent for gastric stenosis or obstruction, and pain control with pain medications and radiotherapy.

Sign in / Sign up

Export Citation Format

Share Document